BW VACCINE SURGE MEETING 6 DEC 90

File: 970107_sep96_decls59_0001.txt
Page: 0001
Total Pages: 3

Subject: BW VACCINE SURGE MEETING  6 DEC 90                              

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: BW VACCINE SURGE MEETING                                                                        

Document Number:       1001

Folder Seq  #:         23




                                     UNCLASSIFIED



                                                            6 L)EC 19@@



          DASG-PSZ



          MEMORANDUM FOR RECORD


          SUBJECT: BW VACCINE SURGE MEETING

          1. Reference memorandum from ASD(RA) to Secretary of the Army
          dated 10 November 90, subject: Expansion of Industrial Base for
          Biological Vaccine Production @

          2. A meeting was held with representatives from the Office of
          the Surgeon General and Medical Research and Development Command
          to act on the memorandum from ASD(HA). The attendees are listed
          at Enclosure 1.

          3. Each directive in the ASD(HA) memorandum was addressed
          separately with specific attention to timeliness, potential
          problems in funding. The following summary is provided:

              a.                  Health Service (Production Increase).
          This group is curren y under contract to produce anthrax vaccine and
          now has two additional fermenters (totaling three) so that they can
          potentially produce              of vaccine every six weeks.
          The FDA will however not license them until tests of the new
          fermenters are completed. This should occur by I February 1991 at
          which time they can begin full production. Funding is already
          written into the new contract and no additional monies are
          needed at this time.

              b. Lederle-Praxis (New Contract). The company has one 300
          liter fermenter in an old facility, however the fermenter has
          been well maintained.  They need FDA approval, vaccination for
          their personnel and a letter contract from us to begin
          production. We will provide the letter contract with start up
          funds of $150,000 immediately and they will begin facility
          opening, personnel vaccination, etc. They should be able to
proval and
          then bulk product will be available approximately by the middle
          to late March.

              C. National Cancer Institute (New Agreement). This group
          has six 200 liter fermenters in an old facility with renovation
          and FDA Inspection and approval required. Vaccination of
          personnel is also necessary. They are hiring personnel now and
          need six weeks to begin production and to acquire the appropriate
          levels of antibody production and approvals. Start up costs are
          $200,000.


          DECLASSIFIED
          ON: 17 DEC 96                            CLASS[FFED BY-
          BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958


                                                   U-@L@6@iFY ON:

Document 3 f:/Week-36/BX003201/BW VACCINE SURGE MEETING/bw vaccine surge meeting 6 dec 90:01029715474660
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = BW VACCINE SURGE MEETING
Folder Seq # = 23
Subject = BW VACCINE SURGE MEETING 6 DEC 90
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997